GPX4 and type 2 diabetes mellitus: In our in vivo experiments, we established a T2DM mouse model and orally administered PMS to explore its therapeutic efficacy and its impact on pancreatic tissue ferroptosis, alongside evaluating the expression levels of factors linked to the xCT/GPX4 pathway.